Ultragenyx Pharmaceutical Inc. reports acquisition or asset disposition

Ultragenyx Pharmaceutical Inc. filed an 8-K covering an acquisition or disposition of assets, results of operations or financial condition, and SEC Item 2.05. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.